AI assistant
CANCOM SE — Investor Presentation 2014
May 15, 2014
71_rns_2014-05-15_99548fa7-be5d-412e-be3c-f0f889942102.pdf
Investor Presentation
Open in viewerOpens in your device viewer
(TecDAX, Software/IT)
| Value Indicators: | EUR | Share data: | Description: | ||||
|---|---|---|---|---|---|---|---|
| Buy | DCF: | 43.10 | Bloomberg: | COK GR | |||
| FCF-Value Potential 16e: | 40.00 | Reuters: | COKG | One of the three largest independent system houses in Germany |
|||
| EUR 43.00 | ISIN: | DE0005419105 | |||||
| Market Snapshot: | EUR m | Shareholders: | Risk Profile (WRe): | 2014e | |||
| Market cap: | 513.0 | Freefloat | 96.0 % | Beta: | 1.2 | ||
| Price | EUR 35.13 | No. of shares (m): | 14.6 | Klaus Weinmann (CEO) | 2.0 % | Price / Book: | 2.9 x |
| Upside | 22.4 % | EV: | 473.1 | S. Kober (Superv. Board) | 2.0 % | Equity Ratio: | 47 % |
| Freefloat MC: | 492.5 | Net Fin. Debt / EBITDA: | -0.8 x | ||||
| Ø Trad. Vol. (30d; EUR): | 4.75 m | Net Debt / EBITDA: | -0.8 x |
Final Q1: Cloud reported separately
| Stated Figures Q1/2014: | Comment on Figures: | |||||||
|---|---|---|---|---|---|---|---|---|
| Figures in EUR m | Q1/14 Q1/14e | Q1/13 | yoy | 2014e | 2013 | yoy | The new Cloud Solutions segment comprises the cloud business (also | |
| Sales | 185.4 | 185.4 | 135.1 | 37.3% | 780.0 | 613.8 | 27.1% | the related consulting and implementation) as well as the managed services business. |
| EBITDA | 10.1 | 10.1 | 7.0 | 45.1% | 51.5 | 33.4 | 54.2% | The IT Solutions segment includes CANCOM's traditional business |
| margin | 5.5% | 5.4% | 5.2% | 6.6% | 5.4% | which encompasses IT consulting, system integration, procurement and | ||
| EBIT | 4.8 | 4.1 | 4.8 | -0.9% | 30.5 | 22.6 | 34.6% | e-commerce. |
| margin | 2.6% | 2.2% | 3.6% | 3.9% | 3.7% | The recent acquisitions including Pironet (part of the Cloud Solutions | ||
| EBIT adjusted | 7.2 | 7.0 | 5.1 | 40.8% | 42.4 | 22.6 | 87.0% | segment), on line Datensysteme and HPM contributed to top-line growth. |
| margin | 3.9% | 3.8% | 3.8% | 5.4% | 3.7% | M&A-related costs of EUR 0.5m negatively impacted the bottom line. | ||
| EPS | 0.21 | 0.17 | 0.28 | -25.0% | 1.38 | 1.23 | 12.2% | Thus, adj. EBITDA was EUR 10.6m. Further adjustments at EBIT level |
| margin | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | are related to PPA-amortisation. | ||
| EPS adjusted | 0.33 | 0.31 | 0.30 | 10.0% | 1.94 | 1.32 | 47.0% | The number of shares increased from 11.4m to more than 14m due to |
| Cloud Solutions | 20.7 | n.a. | 10.8 | 92.7% | 0.0 | 0.0 | - | the capital increase in conjunction with the Pironet acquisition as well as |
| EBITDA Cloud Solutions | 4.3 | n.a. | 2.2 | 99.3% | 0.0 | 0.0 | - | the acquisition of on line Datensysteme. Thus, adj. EPS grew only |
| margin | 21.0% | - | 20.3% | - | - | slightly. | ||
| IT Solutions | 164.7 | n.a. | 124.3 | 32.5% | 0.0 | 0.0 | - | Organic growth is expected to have reached a double-digit rate. |
| EBITDA IT Solutions | 8.6 | n.a. | 6.4 | 34.6% | 0.0 | 0.0 | - | |
| margin | 5.2% | - | 5.2% | - | - |
CANCOM has released final Q1 figures, confirming preliminaries.
Along with the figures, the company also introduced a new segment structure. CANCOM now reports the cloud computing business separately, which soared by more than 90% yoy. This increase was supported by Pironet's Cloud Computing segment which recorded revenues of EUR 9.6m (+13% yoy) in Q1. We assume that HPM Networks figures are also included in the Q1 2014 figures as the company has been consolidated since March. Adjusting the figures for Pironet raises the question of CANCOM's organic growth in the cloud which needs further clarification.
CANCOM is among the early movers in the cloud computing market for mid-sized enterprises. Via the Pironet acquisition, CANCOM has strengthened its position in order to monetise its cloud portfolio, which is composed of its proprietary cloud architecture software AHP Private Cloud as well as its data centres which have become part of the CANCOM group since the acquisition of Pironet. The acquisition of HPM Networks in the U.S., a value-added reseller in the area of cloud infrastructure, will serve as a hub in order to expand in the U.S. market. HP will also play a role in CANCOM's German operations in the context of a cooperation agreement: The IT giant will market CANCOM's proprietary AHP Private Cloud solution to mid-sized companies with 500-7,000 PC seats. The Buy rating as well as the PT of EUR 43 are reiterated.
| FY End: 31.12. | CAGR | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| in EUR m | (13-16e) | 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e | |
| Sales | 12.8 % | 474.6 | 544.4 | 558.1 | 613.8 | 780.0 | 830.0 | 880.0 | |
| Change Sales yoy | 12.3 % | 14.7 % | 2.5 % | 10.0 % | 27.1 % | 6.4 % | 6.0 % | ||
| Gross profit margin | 29.4 % | 29.1 % | 29.7 % | 30.2 % | 31.2 % | 30.8 % | 30.8 % | ||
| EBITDA | 27.9 % | 19.0 | 25.0 | 28.1 | 33.4 | 51.5 | 63.7 | 69.8 | |
| Margin | 4.0 % | 4.6 % | 5.0 % | 5.4 % | 6.6 % | 7.7 % | 7.9 % | ||
| EBIT adj. | 37.8 % | 15.2 | 18.5 | 20.7 | 22.6 | 42.4 | 53.4 | 59.3 | |
| EBIT | 32.6 % | 15.2 | 18.5 | 20.7 | 22.6 | 30.5 | 44.9 | 52.8 | |
| Margin | 3.2 % | 3.4 % | 3.7 % | 3.7 % | 3.9 % | 5.4 % | 6.0 % | ||
| Net income | 35.0 % | 7.8 | 11.5 | 11.5 | 14.5 | 20.2 | 30.3 | 35.8 | |
| EPS | 24.8 % | 0.76 | 1.11 | 1.09 | 1.23 | 1.38 | 2.03 | 2.39 | |
| DPS | 14.5 % | 0.15 | 0.30 | 0.35 | 0.40 | 0.45 | 0.50 | 0.60 | |
| Rel. Performance vs TecDAX: | Dividend Yield | 2.2 % | 3.4 % | 2.9 % | 2.0 % | 1.3 % | 1.4 % | 1.7 % | |
| FCFPS | 0.86 | 1.67 | 0.34 | 0.94 | 2.64 | 2.69 | 2.65 | ||
| 1 month: | 12.3 % EV / Sales |
0.1 x | 0.1 x | 0.2 x | 0.3 x | 0.6 x | 0.6 x | 0.5 x | |
| 6 months: | 21.1 % EV / EBITDA |
3.7 x | 2.9 x | 3.5 x | 5.2 x | 9.2 x | 7.2 x | 6.2 x | |
| Year to date: | 7.8 % EV / EBIT |
4.6 x | 3.9 x | 4.7 x | 7.7 x | 15.5 x | 10.3 x | 8.2 x | |
| Trailing 12 months: | EV / EBIT adj. 75.8 % |
4.6 x | 3.9 x | 4.7 x | 7.7 x | 11.2 x | 8.6 x | 7.3 x | |
| P / E | 9.0 x | 8.0 x | 11.0 x | 16.4 x | 25.4 x | 17.3 x | 14.7 x | ||
| Company events: | FCF Yield Potential | 9.1 % | 15.7 % | 9.8 % | 10.9 % | 5.2 % | 8.9 % | 10.3 % | |
| 25.06.14 | AGM Net Debt |
-0.8 | -20.5 | -29.1 | -62.4 | -39.9 | -71.0 | -97.6 | |
| 07.08.14 | Q2 ROE |
16.5 % | 20.6 % | 16.2 % | 11.9 % | 12.5 % | 17.7 % | 18.4 % | |
| 11.11.14 | ROCE (NOPAT) Q3 |
24.1 % | 29.0 % | 29.1 % | 20.1 % | 17.8 % | 23.6 % | 29.1 % | |
| Guidance: | 2014: EBITDA EUR 50m | ||||||||
| A n a l y s t |
Andreas Wolf [email protected] +49 40 309537-140
Company Background
- Cancom is the third-largest independent system house in Germany.
- The range of products and services the company offers includes the sale of hardware and software of all the main producers as well as IT-services (conception, integration and operation of IT systems).
- The company employs more than 2,000 people in more than 30 locations in Germany and Austria. More than half of the employees work in the service business areas.
Competitive Quality
- The German system house market is intensely competitive and strongly fragmented. As one of the largest system houses in Germany, Cancom achieves competitive advantages over most of its smaller competitors with…
- …favourable purchasing conditions
- …the wide range of products and services offered as a one-stop-shop supplier
- …its presence in more than 30 locations in Germany, which contributes to a high quality of service on location.
- Acquisitions are a part of the company strategy. These serve to improve purchasing conditions, to build up regional presence and extend the range of products and services on offer.
DCF model Detailed forecast period Transitional period Term. Value Figures in EUR m 2014e 2015e 2016e 2017e 2018e 2019e 2020e 2021e 2022e 2023e 2024e 2025e 2026e Sales 780.0 830.0 880.0 909.0 937.5 965.5 992.8 1,019.5 1,045.5 1,070.9 1,095.5 1,119.5 1,141.9 Sales change 27.1 % 6.4 % 6.0 % 3.3 % 3.1 % 3.0 % 2.8 % 2.7 % 2.6 % 2.4 % 2.3 % 2.2 % 2.0 % 2.0 % EBIT 30.5 44.9 52.8 57.3 59.1 60.8 62.5 64.2 65.9 67.5 69.0 70.5 71.9 EBIT-margin 3.9 % 5.4 % 6.0 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % 6.3 % Tax rate (EBT) 30.5 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % 30.0 % NOPAT 21.2 31.4 37.0 40.1 41.3 42.6 43.8 45.0 46.1 47.2 48.3 49.4 50.4 Depreciation 21.0 18.8 17.0 13.6 14.1 14.5 14.9 15.3 15.7 16.1 16.4 16.8 17.1 in % of Sales 2.7 % 2.3 % 1.9 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % 1.5 % Changes in provisions -0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Change in Liquidity from - Working Capital -10.6 -0.9 3.5 4.4 0.6 0.6 0.6 0.6 0.6 0.6 0.5 0.5 0.5 - Capex 19.7 10.5 10.5 15.0 15.5 15.9 16.4 16.8 17.3 17.7 18.1 18.5 18.8 Capex in % of Sales 2.5 % 1.3 % 1.2 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % 1.7 % Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Free Cash Flow (WACC Model) 33.0 40.6 40.0 34.3 39.3 40.5 41.7 42.8 44.0 45.1 46.1 47.2 48.2 49 PV of FCF 33.0 37.3 33.7 26.6 27.9 26.4 25.0 23.6 22.2 20.9 19.6 18.4 17.3 254 share of PVs 17.75 % 38.87 % 43.39 % Model parameter Valuation (m) Derivation of WACC: Derivation of Beta: Present values 2026e 332 Terminal Value 254 Debt ratio 5.00 % Financial Strength 1.20 Financial liabilities 15 Cost of debt (after tax) 2.5 % Liquidity (share) 1.20 Pension liabilities 0 Market return 8.00 % Cyclicality 1.20 Hybrid capital 0
WACC 8.92 % Beta 1.23 Equity Value 631 Value per share (EUR) 43.14
| Sensitivity Value per Share (EUR) | |||
|---|---|---|---|
| Terminal Growth | Delta EBIT-margin | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta WACC | 1.25 % | 1.50 % | 1.75 % | 2.00 % | 2.25 % | 2.50 % | 2.75 % | Beta WACC | -1.5 pp | -1.0 pp | -0.5 pp +0.0 pp | +0.5 pp | +1.0 pp | +1.5 pp | |
| 1.42 9.9 % | 37.16 | 37.52 | 37.92 | 38.33 | 38.78 | 39.25 | 39.76 | 1.42 9.9 % | 29.62 | 32.52 | 35.43 | 38.33 | 41.24 | 44.14 | 47.05 |
| 1.33 9.4 % | 39.17 | 39.61 | 40.08 | 40.58 | 41.11 | 41.68 | 42.30 | 1.33 9.4 % | 31.30 | 34.39 | 37.48 | 40.58 | 43.67 | 46.76 | 49.85 |
| 1.28 9.2 % | 40.27 | 40.75 | 41.26 | 41.81 | 42.40 | 43.04 | 43.72 | 1.28 9.2 % | 32.23 | 35.43 | 38.62 | 41.81 | 45.01 | 48.20 | 51.40 |
| 1.23 8.9 % | 41.44 | 41.97 | 42.54 | 43.14 | 43.79 | 44.50 | 45.26 | 1.23 8.9 % | 33.23 | 36.53 | 39.84 | 43.14 | 46.45 | 49.75 | 53.06 |
| 1.18 8.7 % | 42.70 | 43.28 | 43.90 | 44.57 | 45.29 | 46.07 | 46.92 | 1.18 8.7 % | 34.30 | 37.73 | 41.15 | 44.57 | 47.99 | 51.42 | 54.84 |
| 1.13 8.4 % | 44.04 | 44.68 | 45.37 | 46.11 | 46.91 | 47.78 | 48.73 | 1.13 8.4 % | 35.46 | 39.01 | 42.56 | 46.11 | 49.66 | 53.21 | 56.76 |
| 1.04 7.9 % | 47.03 | 47.81 | 48.66 | 49.58 | 50.58 | 51.68 | 52.87 | 1.04 7.9 % | 38.06 | 41.90 | 45.74 | 49.58 | 53.42 | 57.26 | 61.10 |
Others 1.25 Market val. of investments 0
Liquidity 78 No. of shares (m) 14.6
In the long term, company growth is expected to match the growth of the German IT market.
Risk free rate 2.50 % Transparency 1.30 Minority interest 18
Working capital requirements are low despite reseller activities.
Minorities are related to the 25% free float share in Pironet.
Free Cash Flow Value Potential
Warburg Research's valuation tool "FCF Value Potential" reflects the ability of the company to generate sustainable free cash flows. It is based on the "FCF potential" - a FCF "ex growth" figure - which assumes unchanged working capital and pure maintenance capex. A value indication is derived by discounting the "FCF potential" of a given year with the weighted costs of capital. The fluctuating value indications over time add a timing element to the DCF model (our preferred valuation tool).
| in EUR m | 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e |
|---|---|---|---|---|---|---|---|
| Net Income before minorities | 7.9 | 11.7 | 11.6 | 14.5 | 20.8 | 31.0 | 36.6 |
| + Depreciation + Amortisation | 3.8 | 6.6 | 7.4 | 10.7 | 21.0 | 18.8 | 17.0 |
| - Net Interest Income | -1.8 | -1.6 | -1.8 | -1.2 | -0.6 | -0.6 | -0.6 |
| - Maintenance Capex | 7.2 | 8.5 | 11.3 | 7.3 | 17.7 | 9.5 | 9.5 |
| + Other | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| = Free Cash Flow Potential | 6.4 | 11.3 | 9.5 | 19.1 | 24.6 | 40.9 | 44.7 |
| Free Cash Flow Yield Potential | 9.1 % | 15.7 % | 9.8 % | 10.9 % | 5.2 % | 8.9 % | 10.3 % |
| WACC | 8.92 % | 8.92 % | 8.92 % | 8.92 % | 8.92 % | 8.92 % | 8.92 % |
| = Enterprise Value (EV) | 69.8 | 72.2 | 97.3 | 174.9 | 473.1 | 460.0 | 433.4 |
| = Fair Enterprise Value | 71.2 | 126.9 | 106.5 | 214.2 | 276.1 | 458.7 | 501.0 |
| - Net Debt (Cash) | -62.5 | -62.5 | -62.5 | -62.5 | -39.9 | -71.0 | -97.6 |
| - Pension Liabilities | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| - Other | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| - Market value of minorities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.0 | 18.0 |
| + Market value of investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| = Fair Market Capitalisation | 133.7 | 189.4 | 168.9 | 276.6 | 315.9 | 511.7 | 580.6 |
| No. of shares (total) (m) | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 |
| = Fair value per share (EUR) | 9.14 | 12.96 | 11.56 | 18.92 | 21.62 | 35.01 | 39.72 |
| premium (-) / discount (+) in % | -38.4 % | -0.3 % | 13.2 % | ||||
| Sensitivity Fair value per Share (EUR) | |||||||
| 11.92 % | 7.92 | 10.77 | 9.72 | 15.24 | 16.86 | 27.12 | 31.10 |
| 10.92 % | 8.25 | 11.37 | 10.22 | 16.24 | 18.16 | 29.27 | 33.45 |
| 9.92 % | 8.65 | 12.08 | 10.82 | 17.45 | 19.71 | 31.85 | 36.27 |
| WACC 8.92 % |
9.14 | 12.96 | 11.56 | 18.92 | 21.62 | 35.01 | 39.72 |
| 7.92 % | 9.76 | 14.05 | 12.48 | 20.77 | 24.00 | 38.97 | 44.05 |
| 6.92 % | 10.55 | 15.46 | 13.66 | 23.16 | 27.07 | 44.08 | 49.62 |
| 5.92 % | 11.61 | 17.35 | 15.25 | 26.35 | 31.18 | 50.90 | 57.08 |
Business model with low capex requirements and high FCF...
…provides scope for acquisitions and pay-outs to shareholders.
| Valuation | |||||||
|---|---|---|---|---|---|---|---|
| 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e | |
| Price / Book | 1.4 x | 1.5 x | 1.6 x | 1.5 x | 2.9 x | 2.6 x | 2.3 x |
| Book value per share ex intangibles | 0.81 | 2.03 | 3.72 | 9.13 | 4.73 | 6.55 | 8.66 |
| EV / Sales | 0.1 x | 0.1 x | 0.2 x | 0.3 x | 0.6 x | 0.6 x | 0.5 x |
| EV / EBITDA | 3.7 x | 2.9 x | 3.5 x | 5.2 x | 9.2 x | 7.2 x | 6.2 x |
| EV / EBIT | 4.6 x | 3.9 x | 4.7 x | 7.7 x | 15.5 x | 10.3 x | 8.2 x |
| EV / EBIT adj.* | 4.6 x | 3.9 x | 4.7 x | 7.7 x | 11.2 x | 8.6 x | 7.3 x |
| P / FCF | 8.0 x | 5.3 x | 35.1 x | 21.4 x | 14.2 x | 14.0 x | 14.2 x |
| P / E | 9.0 x | 8.0 x | 11.0 x | 16.4 x | 25.4 x | 17.3 x | 14.7 x |
| P / E adj.* | 8.9 x | 8.0 x | 11.0 x | 16.4 x | 18.1 x | 14.4 x | 13.0 x |
| Dividend Yield | 2.2 % | 3.4 % | 2.9 % | 2.0 % | 1.3 % | 1.4 % | 1.7 % |
| Free Cash Flow Yield Potential | 9.1 % | 15.7 % | 9.8 % | 10.9 % | 5.2 % | 8.9 % | 10.3 % |
| *Adjustments made for: - |
Consolidated profit & loss
| In EUR m | 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e |
|---|---|---|---|---|---|---|---|
| Sales | 474.6 | 544.4 | 558.1 | 613.8 | 780.0 | 830.0 | 880.0 |
| Change Sales yoy | 12.3 % | 14.7 % | 2.5 % | 10.0 % | 27.1 % | 6.4 % | 6.0 % |
| Increase / decrease in inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Own work capitalised | 1.3 | 0.9 | 2.5 | 0.4 | 1.2 | 1.2 | 1.2 |
| Total Sales | 475.8 | 545.3 | 560.6 | 614.2 | 781.2 | 831.2 | 881.2 |
| Material Expenses | 336.3 | 386.6 | 395.1 | 428.7 | 538.2 | 575.4 | 610.0 |
| Gross profit | 139.5 | 158.7 | 165.5 | 185.5 | 243.0 | 255.8 | 271.2 |
| Gross profit margin | 29.4 % | 29.1 % | 29.7 % | 30.2 % | 31.2 % | 30.8 % | 30.8 % |
| Personnel expenses | 97.0 | 108.0 | 112.4 | 123.2 | 153.3 | 154.0 | 160.0 |
| Other operating income | 3.4 | 0.7 | 0.6 | 1.1 | 3.9 | 4.2 | 4.4 |
| Other operating expenses | 26.9 | 26.4 | 25.8 | 29.9 | 42.1 | 42.3 | 45.8 |
| Unfrequent items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITDA | 19.0 | 25.0 | 28.1 | 33.4 | 51.5 | 63.7 | 69.8 |
| Margin | 4.0 % | 4.6 % | 5.0 % | 5.4 % | 6.6 % | 7.7 % | 7.9 % |
| Depreciation of fixed assets | 2.1 | 2.8 | 4.0 | 5.5 | 8.0 | 8.0 | 8.0 |
| EBITA | 16.9 | 22.2 | 24.0 | 27.9 | 43.5 | 55.7 | 61.8 |
| Amortisation of intangible assets | 1.7 | 3.7 | 3.4 | 5.0 | 13.0 | 10.8 | 9.0 |
| Goodwill amortization | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 |
| EBIT | 15.2 | 18.5 | 20.7 | 22.6 | 30.5 | 44.9 | 52.8 |
| Margin | 3.2 % | 3.4 % | 3.7 % | 3.7 % | 3.9 % | 5.4 % | 6.0 % |
| EBIT adj. | 15.2 | 18.5 | 20.7 | 22.6 | 42.4 | 53.4 | 59.3 |
| Interest income | 0.1 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
| Interest expenses | 2.0 | 2.2 | 2.1 | 1.4 | 0.9 | 0.9 | 0.9 |
| Other financial income (loss) | 0.0 | 0.4 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 |
| EBT | 13.3 | 16.9 | 18.9 | 21.4 | 29.9 | 44.3 | 52.2 |
| Margin | 2.8 % | 3.1 % | 3.4 % | 3.5 % | 3.8 % | 5.3 % | 5.9 % |
| Total taxes | 3.7 | 4.9 | 6.6 | 6.9 | 9.1 | 13.3 | 15.7 |
| Net income from continuing operations | 9.6 | 12.0 | 12.3 | 14.5 | 20.8 | 31.0 | 36.6 |
| Income from discontinued operations (net of tax) | -1.7 | -0.3 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income before minorities | 7.9 | 11.7 | 11.6 | 14.5 | 20.8 | 31.0 | 36.6 |
| Minority interest | 0.1 | 0.2 | 0.1 | 0.0 | 0.6 | 0.7 | 0.8 |
| Net income | 7.8 | 11.5 | 11.5 | 14.5 | 20.2 | 30.3 | 35.8 |
| Margin | 1.6 % | 2.1 % | 2.1 % | 2.4 % | 2.6 % | 3.6 % | 4.1 % |
| Number of shares, average | 10.3 | 10.4 | 10.6 | 11.8 | 14.6 | 14.9 | 14.9 |
| EPS | 0.76 | 1.11 | 1.09 | 1.23 | 1.38 | 2.03 | 2.39 |
| EPS adj. | 0.77 | 1.11 | 1.09 | 1.23 | 1.94 | 2.43 | 2.70 |
| *Adjustments made for: |
Guidance: 2014: EBITDA EUR 50m
Financial Ratios
| 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e | |
|---|---|---|---|---|---|---|---|
| Total Operating Costs / Sales | 96.3 % | 95.6 % | 95.4 % | 94.6 % | 93.6 % | 92.5 % | 92.2 % |
| Operating Leverage | 9.6 x | 1.5 x | 4.8 x | 1.0 x | 1.3 x | 7.4 x | 2.9 x |
| EBITDA / Interest expenses | 9.7 x | 11.2 x | 13.1 x | 24.0 x | 57.2 x | 70.7 x | 77.6 x |
| Tax rate (EBT) | 28.1 % | 28.8 % | 35.0 % | 32.4 % | 30.5 % | 30.0 % | 30.0 % |
| Dividend Payout Ratio | 16.1 % | 25.9 % | 30.2 % | 32.5 % | 31.7 % | 24.1 % | 24.5 % |
| Sales per Employee | 248,075 | 267,377 | 273,569 | 275,738 | 312,000 | 325,490 | 338,462 |
Sales, EBITDA in EUR m
Source: Warburg Research
Performance per Share
Source: Warburg Research
Consolidated balance sheet
| In EUR m | 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Goodwill and other intangible assets | 42.5 | 39.6 | 41.2 | 55.3 | 91.2 | 83.4 | 77.4 |
| thereof other intangible assets | 1.8 | 3.8 | 6.1 | 4.9 | 34.1 | 26.3 | 20.3 |
| thereof Goodwill | 23.7 | 23.7 | 24.3 | 32.7 | 56.4 | 56.4 | 56.4 |
| Property, plant and equipment | 9.7 | 12.9 | 17.6 | 20.5 | 29.5 | 29.0 | 31.5 |
| Financial assets | 3.3 | 1.4 | 1.8 | 31.6 | 31.6 | 31.6 | 31.6 |
| Other long-term assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets | 55.5 | 53.8 | 60.6 | 107.4 | 152.2 | 143.9 | 140.4 |
| Inventories | 14.1 | 15.6 | 9.4 | 16.3 | 11.1 | 11.9 | 12.6 |
| Accounts receivable | 68.0 | 72.2 | 88.3 | 112.9 | 106.8 | 111.4 | 118.1 |
| Liquid assets | 31.5 | 46.4 | 44.6 | 77.7 | 97.4 | 120.5 | 147.1 |
| Other short-term assets | 8.4 | 6.8 | 5.7 | 7.1 | 7.1 | 7.1 | 7.1 |
| Current assets | 122.0 | 141.0 | 148.1 | 214.1 | 222.4 | 250.9 | 284.9 |
| Total Assets | 177.4 | 194.9 | 208.6 | 321.5 | 374.6 | 394.8 | 425.3 |
| Liabilities and shareholders' equity | |||||||
| Subscribed capital | 10.4 | 10.4 | 11.4 | 14.6 | 14.6 | 14.6 | 14.6 |
| Capital reserve | 15.9 | 15.9 | 26.1 | 94.6 | 94.6 | 94.6 | 94.6 |
| Retained earnings | 24.8 | 34.7 | 43.1 | 53.6 | 69.1 | 92.8 | 121.1 |
| Other equity components | -0.1 | -0.3 | 0.0 | 0.0 | -18.0 | -20.8 | -23.5 |
| Shareholder's equity | 50.9 | 60.7 | 80.6 | 162.8 | 160.2 | 181.1 | 206.7 |
| Minority interest | 0.1 | 0.2 | 0.2 | 0.1 | 17.6 | 17.6 | 17.6 |
| Total equity | 51.0 | 60.9 | 80.8 | 162.9 | 177.8 | 198.7 | 224.3 |
| Provisions | 3.3 | 7.7 | 5.2 | 4.5 | 4.4 | 4.4 | 4.4 |
| thereof provisions for pensions and similar obligations | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Financial liabilites (total) | 30.6 | 25.9 | 15.4 | 15.2 | 57.5 | 49.5 | 49.5 |
| thereof short-term financial liabilities | 1.2 | 10.6 | 3.4 | 2.7 | 2.7 | 2.7 | 2.7 |
| Accounts payable | 64.4 | 72.9 | 76.9 | 99.0 | 98.3 | 104.6 | 108.5 |
| Other liabilities | 28.1 | 27.6 | 30.3 | 39.9 | 36.6 | 37.6 | 38.6 |
| Liabilities | 126.4 | 134.0 | 127.9 | 158.6 | 196.7 | 196.0 | 200.9 |
| Total liabilities and shareholders' equity | 177.4 | 194.9 | 208.6 | 321.5 | 374.6 | 394.8 | 425.3 |
Financial Ratios
| 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e | |
|---|---|---|---|---|---|---|---|
| Efficiency of Capital Employment | |||||||
| Operating Assets Turnover | 18.4 x | 21.0 x | 16.1 x | 13.9 x | 18.3 x | 20.2 x | 18.7 x |
| Capital Employed Turnover | 9.5 x | 13.5 x | 10.8 x | 6.1 x | 5.7 x | 6.5 x | 6.9 x |
| ROA | 14.1 % | 21.4 % | 18.9 % | 13.5 % | 13.2 % | 21.0 % | 25.5 % |
| Return on Capital | |||||||
| ROCE (NOPAT) | 24.1 % | 29.0 % | 29.1 % | 20.1 % | 17.8 % | 23.6 % | 29.1 % |
| ROE | 16.5 % | 20.6 % | 16.2 % | 11.9 % | 12.5 % | 17.7 % | 18.4 % |
| Adj. ROE | 16.7 % | 20.6 % | 16.2 % | 11.9 % | 17.6 % | 21.2 % | 20.8 % |
| Balance sheet quality | |||||||
| Net Debt | -0.8 | -20.5 | -29.1 | -62.4 | -39.9 | -71.0 | -97.6 |
| Net Financial Debt | -0.9 | -20.5 | -29.2 | -62.5 | -39.9 | -71.0 | -97.6 |
| Net Gearing | -1.6 % | -33.6 % | -36.0 % | -38.3 % | -22.4 % | -35.7 % | -43.5 % |
| Net Fin. Debt / EBITDA | -4.8 % | -82.2 % | -104.1 % | -187.3 % | -77.5 % | -111.6 % | -139.8 % |
| Book Value / Share | 4.9 | 5.8 | 7.6 | 13.8 | 11.0 | 12.1 | 13.8 |
| Book value per share ex intangibles | 0.8 | 2.0 | 3.7 | 9.1 | 4.7 | 6.5 | 8.7 |
CO M M E N T Published 15.05.2014 7
Consolidated cash flow statement
| In EUR m | 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e |
|---|---|---|---|---|---|---|---|
| Net income | 7.9 | 11.7 | 11.6 | 14.5 | 20.8 | 31.0 | 36.6 |
| Depreciation of fixed assets | 2.1 | 2.8 | 4.0 | 5.5 | 8.0 | 8.0 | 8.0 |
| Amortisation of goodwill | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 |
| Amortisation of intangible assets | 1.7 | 3.7 | 3.4 | 5.0 | 13.0 | 10.8 | 9.0 |
| Increase/decrease in long-term provisions | 0.3 | 0.1 | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 |
| Other non-cash income and expenses | 2.0 | 4.6 | -1.0 | -2.1 | 6.0 | 0.0 | 0.0 |
| Cash Flow | 14.0 | 22.9 | 17.9 | 23.1 | 47.7 | 49.8 | 53.6 |
| Increase / decrease in inventory | 0.5 | -6.3 | 6.3 | -5.1 | 5.2 | -0.8 | -0.7 |
| Increase / decrease in accounts receivable | -14.7 | -5.2 | -16.4 | -20.3 | 6.1 | -4.6 | -6.7 |
| Increase / decrease in accounts payable | 17.2 | 15.3 | 8.4 | 21.5 | -0.7 | 6.3 | 3.9 |
| Increase / decrease in other working capital positions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Increase / decrease in working capital (total) | 2.9 | 3.8 | -1.8 | -3.9 | 10.6 | 0.9 | -3.5 |
| Net cash provided by operating activities | 16.9 | 26.7 | 16.1 | 19.2 | 58.3 | 50.7 | 50.1 |
| Investments in intangible assets | -3.0 | -2.8 | -1.1 | -0.7 | -2.7 | -3.0 | -3.0 |
| Investments in property, plant and equipment | -5.0 | -6.6 | -11.4 | -7.5 | -17.0 | -7.5 | -7.5 |
| Payments for acquisitions | -9.7 | -3.6 | -0.6 | -1.4 | -79.0 | -3.0 | -6.0 |
| Financial investments | 0.0 | 0.0 | 0.0 | -28.9 | 0.0 | 0.0 | 0.0 |
| Income from asset disposals | 0.5 | 5.1 | 2.5 | 3.4 | 0.5 | 0.5 | 0.5 |
| Net cash provided by investing activities | -17.3 | -7.9 | -10.6 | -35.2 | -98.2 | -13.0 | -16.0 |
| Change in financial liabilities | 8.3 | -4.3 | -13.2 | -1.8 | 42.3 | -8.0 | 0.0 |
| Dividends paid | -1.5 | -1.6 | -3.3 | -4.0 | -4.7 | -6.6 | -7.5 |
| Purchase of own shares | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Capital measures | 0.0 | 0.0 | 11.4 | 56.1 | 0.0 | 0.0 | 0.0 |
| Other | -1.5 | 0.1 | -0.3 | -1.2 | 0.0 | 0.0 | 0.0 |
| Net cash provided by financing activities | 5.9 | -5.8 | -5.3 | 49.1 | 37.6 | -14.6 | -7.5 |
| Change in liquid funds | 5.5 | 13.0 | 0.2 | 33.1 | -2.4 | 23.1 | 26.6 |
| Effects of exchange-rate changes on cash | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash and cash equivalent at end of period | 31.5 | 44.5 | 44.6 | 77.7 | 75.4 | 120.5 | 147.1 |
Financial Ratios
| 2010 | 2011 | 2012 | 2013 | 2014e | 2015e | 2016e | |
|---|---|---|---|---|---|---|---|
| Cash Flow | |||||||
| FCF | 8.9 | 17.3 | 3.6 | 11.1 | 38.6 | 40.2 | 39.6 |
| Free Cash Flow / Sales | 1.9 % | 3.2 % | 0.6 % | 1.8 % | 5.0 % | 4.8 % | 4.5 % |
| Free Cash Flow Potential | 6.4 | 11.3 | 9.5 | 19.1 | 24.6 | 40.9 | 44.7 |
| Free Cash Flow / Sales | 1.9 % | 3.2 % | 0.6 % | 1.8 % | 5.0 % | 4.8 % | 4.5 % |
| Free Cash Flow / Net Profit | 113.4 % | 150.3 % | 31.4 % | 76.2 % | 191.5 % | 132.7 % | 110.6 % |
| Interest Received / Avg. Cash | 0.5 % | 0.8 % | 0.8 % | 0.5 % | 0.3 % | 0.3 % | 0.2 % |
| Interest Paid / Avg. Debt | 7.4 % | 7.9 % | 10.4 % | 9.1 % | 2.5 % | 1.7 % | 1.8 % |
| Management of Funds | |||||||
| Investment ratio | 1.7 % | 1.7 % | 2.2 % | 1.3 % | 2.5 % | 1.3 % | 1.2 % |
| Maint. Capex / Sales | 1.5 % | 1.6 % | 2.0 % | 1.2 % | 2.3 % | 1.1 % | 1.1 % |
| Capex / Dep | 208.3 % | 143.6 % | 169.0 % | 75.8 % | 93.8 % | 55.9 % | 61.8 % |
| Avg. Working Capital / Sales | 2.9 % | 2.7 % | 2.7 % | 3.3 % | 2.4 % | 1.5 % | 1.6 % |
| Trade Debtors / Trade Creditors | 105.6 % | 99.0 % | 114.8 % | 114.1 % | 108.6 % | 106.5 % | 108.8 % |
| Inventory Turnover | 23.9 x | 24.8 x | 42.0 x | 26.3 x | 48.5 x | 48.3 x | 48.4 x |
| Receivables collection period (days) | 52 | 48 | 58 | 67 | 50 | 49 | 49 |
| Payables payment period (days) | 70 | 69 | 71 | 84 | 67 | 66 | 65 |
| Cash conversion cycle (Days) | -54 | -54 | -64 | -73 | -63 | -62 | -60 |
CAPEX and Cash Flow in EUR m
Working Capital
CO M M E N T Published 15.05.2014 8
LEGAL DISCLAIMER
This research report was prepared by the Warburg Research GmbH, a subsidiary of the M.M.Warburg & CO KGaA and is passed on by the M.M.Warburg & CO KGaA. It contains selected information and does not purport to be complete. The report is based on publicly available information and data ("the information") believed to be accurate and complete. Warburg Research GmbH neither does examine the information to be accurate and complete, nor guarantees its accuracy and completeness. Possible errors or incompleteness of the information do not constitute grounds for liability of M.M.Warburg & CO KGaA or Warburg Research GmbH for damages of any kind whatsoever, and M.M.Warburg & CO KGaA and Warburg Research GmbH are not liable for indirect and/or direct and/or consequential damages. In particular, neither M.M.Warburg & CO KGaA nor Warburg Research GmbH are liable for the statements, plans or other details contained in these analyses concerning the examined companies, their affiliated companies, strategies, economic situations, market and competitive situations, regulatory environment, etc. Although due care has been taken in compiling this research report, it cannot be excluded that it is incomplete or contains errors. M.M.Warburg & CO KGaA and Warburg Research GmbH, their shareholders and employees are not liable for the accuracy and completeness of the statements, estimations and the conclusions derived from the information contained in this document. Provided a research report is being transmitted in connection with an existing contractual relationship, i.e. financial advisory or similar services, the liability of M.M.Warburg & CO KGaA and Warburg Research GmbH shall be restricted to gross negligence and wilful misconduct. In case of failure in essential tasks, M.M.Warburg & CO KGaA and Warburg Research GmbH are liable for normal negligence. In any case, the liability of M.M.Warburg & CO KGaA and Warburg Research GmbH is limited to typical, expectable damages. This research report does not constitute an offer or a solicitation of an offer for the purchase or sale of any security. Partners, directors or employees of M.M.Warburg & CO KGaA, Warburg Research GmbH or affiliated companies may serve in a position of responsibility, i.e. on the board of directors of companies mentioned in the report. Opinions expressed in this report are subject to change without notice. All rights reserved.
COPYRIGHT NOTICE
This work including all its parts is protected by copyright. Any use beyond the limits provided by copyright law without permission is prohibited and punishable. This applies, in particular, to reproductions, translations, microfilming, and storage and processing on electronic media of the entire content or parts thereof.
DISCLOSURE ACCORDING TO §34B (1) OF THE GERMAN SECURITIES TRADING ACT (WHPG) AND THE ORDINANCE ON THE ANALYSIS OF FINANCIAL INSTRUMENTS (FINANV)
The valuation underlying the investment recommendation for the company analysed here is based on generally accepted and widely used methods of fundamental analysis, such as e.g. DCF Model, Free Cash Flow Potential, Peer Group Comparison or Sum of the Parts Model. The result of this fundamental valuation is modified to take into consideration the analyst's assessment as regards the expected development of investor sentiment and its impact on the share price.
Independent of the applied valuation methods, there is the risk that the price target will not be met, for instance because of unforeseen changes in demand for the company's products, changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, tax rate etc. For investments in foreign markets and instruments there are further risks, generally based on exchange rate changes or changes in political and social conditions.
This commentary reflects the opinion of the relevant author at the point in time of its compilation. A change in the fundamental factors underlying the valuation can mean that the valuation is subsequently no longer accurate. Whether, or in what time frame, an update of this commentary follows is not determined in advance.
In accordance with § 5 (4) of the Ordinance on the Analysis of Financial Instruments (FinAnV) Warburg Research GmbH has implemented additional internal and organisational arrangements to prevent or to deal with conflicts of interest. Among these are the spatial separation of Warburg Research GmbH from M.M.Warburg & CO KGaA and the creation of areas of confidentiality. This prevents the exchange of information, which could form the basis of conflicts of interest for Warburg Research in terms of the analysed issuers or their financial instruments.
The analysts of Warburg Research GmbH do not receive a gratuity – directly or indirectly – from the investment banking activities of M.M.Warburg & CO KGaA or of any company within the Warburg Group.
All prices of financial instruments given in this financial analysis are the closing prices on the last stock-market trading day before the publication date stated, unless another point in time is explicitly stated.
M.M.Warburg & CO KGaA and Warburg Research GmbH are subject to the supervision of the Federal Financial Supervisory Authority, BaFin.
SOURCES
All data and consensus estimates have been obtained from FactSet except where stated otherwise.
Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a securities analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis. A conflict of interest is assumed, in particular, when the enterprise preparing the analysis …
| -1- | … or companies affiliated with this enterprise holds 5% or more of the share capital of the analysed company |
|---|---|
| -2- | … or companies affiliated with this enterprise were involved in the management of a consortium for a public offering of securities which are or whose issuer is the subject of this report within the last twelve months |
| -3- | … or companies affiliated with this enterprise manages the securities of the analysed company on the basis of an existing contract |
| -4- | … or companies affiliated with this enterprise over the previous 12 months has been providing investment banking services for the analysed company for which a compensation has been or will be paid. Warburg Research GmbH receives indirect remuneration from the investment banking activities of M.M.Warburg & CO KGaA. |
| -5- | … effected an agreement with the analysed company for the preparation of the financial analysis |
| -6- | … or companies affiliated with this enterprise regularly trade in shares or derivatives of the analysed company |
| -7- | … or the analyst responsible for this company has other important financial interests in relation to the analysed company such as e.g. the performance of mandates for the analysed company |
| Company | Disclosure | Link to the historical price targets and rating changes (last 12 months) |
|---|---|---|
| CANCOM | 5 | http://www.mmwarburg.com/disclaimer/disclaimer_en/DE0005419105.htm |
INVESTMENT RECOMMENDATION
Investment recommendation: expected direction of the share price development of the financial instrument up to the given price target in the opinion of the analyst who covers this financial instrument.
| -B- | Buy: | The price of the analysed financial instrument is expected to rise over the next 12 months. | |
|---|---|---|---|
| -H- | Hold: | The price of the analysed financial instrument is expected to remain mostly flat over the next 12 months. |
|
| -S- | Sell: | The price of the analysed financial instrument is expected to fall over the next 12 months. | |
| "-" | Rating suspended: | The available information currently does not permit an evaluation of the company. |
WARBURG RESEARCH GMBH – RESEARCH UNIVERSE BY RATING
| Rating | Number of stocks | % of Universe |
|---|---|---|
| Buy | 106 | 54 |
| Hold | 78 | 39 |
| Sell | 11 | 6 |
| Rating suspended | 3 | 2 |
| Total | 198 | 100 |
WARBURG RESEARCH GMBH – ANALYSED RESEARCH UNIVERSE BY RATING …
… Looking only at companies for which a disclosure according to § 34b of the Germany Securities Trading Act and the FinAnV has to be made.
| Rating | Number of stocks | % of Universe |
|---|---|---|
| Buy | 82 | 58 |
| Hold | 51 | 36 |
| Sell | 6 | 4 |
| Rating suspended | 2 | 1 |
| Total | 141 | 100 |
PRICE AND RATING HISTORY CANCOM AS OF 15.05.2014
The chart has markings if Warburg Research GmbH changed its rating in the last 12 months. Every marking represents the date and closing price on the day of the rating change.
RESEARCH
Dep. Head of Equity Sales, GER [email protected] Sales Trading [email protected]
Marie-Therese Grübner +49 40 3282-2630 Jörg Treptow +49 40 3262-2658
Dirk Rosenfelder +49 40 3282-2692
Philipp Stumpfegger +49 40 3282-2635
Software, IT [email protected] Utilities [email protected]
Health Care, Pharma [email protected] Chemicals, Agriculture [email protected]
Engineering [email protected] Software, IT [email protected]
United Kingdom [email protected] Sales Trading [email protected]
United Kingdom [email protected] Sales Trading [email protected]
France [email protected] Sales Trading [email protected]
Ömer Güven +49 40 3282-2633 Jan Walter +49 40 3262-2662 Germany [email protected] Sales Trading [email protected]
United Kingdom [email protected] Roadshow/Marketing [email protected]
Marc Niemann +49 40 3282-2660 Germany [email protected]
Austria, Switzerland [email protected]
Australia, United Kingdom [email protected]
SALES SALES TRADING
MACRO RESEARCH
Roland Rapelius +49 40 309537-220 Andreas Pläsier +49 40 309537-246 Head of Research [email protected] Banks, Financial Services [email protected]
Henner Rüschmeier +49 40 309537-270 Malte Räther +49 40 309537-185 Head of Research hrueschmeier @warburg-research.com Technology, Telco, Internet [email protected]
Christian Cohrs +49 40 309537-175 Jochen Reichert +49 40 309537-130 Engineering, Logistics [email protected] Telco, Internet, Media [email protected]
Felix Ellmann +49 40 309537-120 Christopher Rodler +49 40 309537-290
Jörg Philipp Frey +49 40 309537-258 Malte Schaumann +49 40 309537-170 Retail, Consumer Goods [email protected] Technology [email protected]
Harald Hof +49 40 309537-125 Susanne Schwartze +49 40 309537-155 Medtech [email protected] Telco, Internet, Media [email protected]
Ulrich Huwald +49 40 309537-255 Oliver Schwarz +49 40 309537-250
Thilo Kleibauer +49 40 309537-257 Marc-René Tonn +49 40 309537-259 Retail, Consumer Goods [email protected] Automobiles, Car Suppliers [email protected]
Torsten Klingner +49 40 309537-260 Björn Voss +49 40 309537-254 Real Estate [email protected] Steel, Car Suppliers [email protected]
Eggert Kuls +49 40 309537-256 Andreas Wolf +49 40 309537-140
Frank Laser +49 40 309537-235 Stephan Wulf +49 40 309537-150 Construction, Industrials [email protected] Utilities [email protected]
Holger Nass +49 40 3282-2669 Oliver Merckel +49 40 3282-2634 Head of Equity Sales, USA [email protected] Head of Sales Trading [email protected]
Klaus Schilling +49 40 3282-2664 Gudrun Bolsen +49 40 3282-2679
Christian Alisch +49 40 3282-2667 Michael Ilgenstein +49 40 3282-2700 Scandinavia, Spain [email protected] Sales Trading [email protected]
Tim Beckmann +49 40 3282-2665 Bastian Quast +49 40 3282-2701
Matthias Fritsch +49 40 3282-2696 Thekla Struve +49 40 3282-2668
Michael Kriszun +49 40 3282-2695 Katharina Merckel +49 40 3282-2694
Carsten Klude +49 40 3282-2572 Macro Research [email protected]
Matthias Thiel +49 40 3282-2401 Macro Research [email protected]
Dr. Christian Jasperneite +49 40 3282-2439 Investment Strategy [email protected]
Our research can be found under:
| Andrea Schaper Sales Assistance |
+49 40 3282-2632 [email protected] |
Kerstin Muthig Sales Assistance |
+49 40 3282-2703 [email protected] |
||
|---|---|---|---|---|---|
| For access please contact: | |||||
| FactSet | www.factset.com | Capital IQ | www.capitaliq.com | ||
| Bloomberg | MMWA GO | Reuters | www.knowledge.reuters.com | ||
| Warburg Research | research.mmwarburg.com/en/index.html | Thomson | www.thomson.com | ||